Generable is a pharmaceutical startup founded in 2016 with the slogan "Better Answers from Small Data." The company leverages data from clinical trials and RWE to de-risk and accelerate early clinical trials by benchmarking treatments against synthetic controls, optimizing doses and trials, and assessing treatment and biomarker efficacy. Generable's cloud-based, analytics-ready database and inference API streamline analysis production and reproduction. Originating from the open-source Stan project at Columbia University, Generable recently secured a $120.00K Seed Round investment on 16 January 2017 from Techstars. Based in the United States, the company aims to disrupt the pharmaceutical industry with its innovative approach to data-driven clinical trial optimization.
No recent news or press coverage available for Generable.